A spotlight on early breast cancer study day

Available on-demand until 30 May 2025

What to expect

Leaders in their respective fields will present updates on the management of early breast cancer of all major subtypes: HER2+, triple negative and hormone receptor positive. Patient support approaches for fertility preservation, bone health and menopausal symptoms will be discussed in detail.

Intended audience

All health care professionals who work with breast cancer patients or who have an interest in breast cancer, including: SpR and consultant oncologists, GPs, community nurses, nurse specialists and research nurses.

Last updated: November 2024